QQ客服 官方微博 反馈留言

	A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.
	Liu, S.a; Gao, X.a; Zhang, L.a; Qin, S.a,b; Wei, M.a; Liu, N.a; Zhao, R.a; Li, B.a; Meng, Y.a; Lin, G.a
刊名	European Journal Of Medicinal Chemistry
	2018
卷号	Vol.156页码:21-42
ISSN号	1768-3254
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2895611
专题	天津大学
作者单位	1.aThe State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University, Tianjin, 300071, China 2.bSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, China 3.cTianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, 300457, China
推荐引用方式 GB/T 7714	Liu, S.a,Gao, X.a,Zhang, L.a,et al. A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.[J]. European Journal Of Medicinal Chemistry,2018,Vol.156:21-42.
APA	Liu, S.a.,Gao, X.a.,Zhang, L.a.,Qin, S.a,b.,Wei, M.a.,...&Yang, C.a.(2018).A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway..European Journal Of Medicinal Chemistry,Vol.156,21-42.
MLA	Liu, S.a,et al."A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.".European Journal Of Medicinal Chemistry Vol.156(2018):21-42.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。